Shanghai Henlius Biotech
Clinical trials sponsored by Shanghai Henlius Biotech, explained in plain language.
-
New hope for lung cancer patients: drug combo shows promise in major trial
Disease control OngoingThis study tests whether adding the drug serplulimab to standard chemotherapy and radiation helps people with limited-stage small cell lung cancer live longer without their cancer growing. About 511 adults with this type of lung cancer will take part. The goal is to see if the ne…
Phase: PHASE3 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New drug combo takes on tough lung cancer in Head-to-Head trial
Disease control OngoingThis study tests a new drug, serplulimab, combined with chemotherapy for people with extensive-stage small cell lung cancer who have not had treatment before. It compares this new combination to another approved immunotherapy plus chemotherapy. The goal is to see which works bett…
Phase: PHASE3 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated May 11, 2026 20:51 UTC